HomeNewsIndiaIn Depth | Trace, test, seal, repeat: As cases rise, here's how India is dealing with coronavirus hotspots

In Depth | Trace, test, seal, repeat: As cases rise, here's how India is dealing with coronavirus hotspots

Most of these cases in India have cropped up in what the government has tended to call hotspots, or places— entire districts, cities, wards or even lanes— which have reported a large number of affected patients

April 10, 2020 / 17:57 IST
Story continues below Advertisement

The number of coronavirus cases in India has seen a spike over the course of past few days, with as many as 284 of the over 694 districts in the country reporting at least one case of COVID-19 infection.

As of April 10, the number of cases across India has risen to 6,412 with 199 deaths. As many as 1,297 of those cases have come from Maharashtra. The state has recorded the highest amount of cases, and India's financial capital, Mumbai, has seen a spiraling number of infections.

Story continues below Advertisement

Most of these cases in Mumbai — and across India — have cropped up in what the government has tended to call hotspots, or places — entire districts, cities, wards or even lanes — which have reported a large amount of infections for various reasons, including aggressive testing and the density of the region.

What are hotspots and how are they identified?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show